首页|Insights into the role of RNA m6A modification in the metabolic process and related diseases

Insights into the role of RNA m6A modification in the metabolic process and related diseases

扫码查看
According to the latest consensus,many traditional diseases are considered meta-bolic diseases,such as cancer,type 2 diabetes,obesity,and cardiovascular disease.Currently,metabolic diseases are increasingly prevalent because of the ever-improving living standards and have become the leading threat to human health.Multiple therapy methods have been applied to treat these diseases,which improves the quality of life of many patients,but the overall effect is still unsatisfactory.Therefore,intensive research on the metabolic process and the pathogenesis of metabolic diseases is imperative.N6-methyladenosine(m6A)is an important modification of eukaryotic RNAs.It is a critical regulator of gene expression that is involved in different cellular functions and physiological processes.Many studies have indi-cated that m6A modification regulates the development of many metabolic processes and metabolic diseases.In this review,we summarized recent studies on the role of m6A modifica-tion in different metabolic processes and metabolic diseases.Additionally,we highlighted the potential m6A-targeted therapy for metabolic diseases,expecting to facilitate m6A-targeted strategies in the treatment of metabolic diseases.

Cancerm6A-targeted therapyMetabolic diseaseMetabolismN6-methyladenosine

Haiming Hu、Zhibin Li、Xia Xie、Qiushi Liao、Yiyang Hu、Chunli Gong、Nannan Gao、Huan Yang、Yufeng Xiao、Yang Chen

展开 >

Department of Gastroenterology,Xinqiao Hospital,Army Medical University,Chongqing 400037,China

国家自然科学基金重庆市自然科学基金Undergraduate Scientific Research Cultivation Program of Army Medical University,Chongqing,China

81874196cstc2021jcyjmsxmX05362021XBK22

2024

基因与疾病(英文)

基因与疾病(英文)

ISSN:
年,卷(期):2024.11(4)
  • 1